#USA #Cambridge #Real-World Evidence #health data #TriNetX

TriNetX: The Premier Source for Real-World Data in Research

TriNetX, an esteemed leader in health data analytics, has achieved an impressive milestone by becoming the most cited electronic health record dataset in peer-reviewed studies. In recent analysis of PubMed data up to August 27, 2025, TriNetX has garnered over 2,000 citations, showcasing a remarkable annual growth rate of nearly 80%. This extraordinary achievement positions TriNetX far ahead of its closest competitor, whose citations pale in comparison at just 149.

The surge in citations signifies a growing reliance on TriNetX data among clinical researchers, public health organizations, and healthcare entities worldwide. Just within the first eight months of 2025, the number of citations reached 952, indicating a trajectory to potentially exceed 1,000 citations by year-end for the first time in the company’s history. The trend highlights the increasing recognition of TriNetX's authority in the field of real-world data (RWD).

“Researchers must have confidence in the data they utilize; it needs to pass peer review and yield meaningful insights,” stated Dr. Jeffrey Brown, Chief Scientific Officer at TriNetX. “Our status as the most cited dataset reflects both the scale and quality of our offerings, and the trust the international research community places in our platform to further scientific understanding and improve patient care.”

TriNetX data has been instrumental in studies published in prominent medical journals, including Nature Medicine, The Journal of Allergy and Clinical Immunology, and JAMIA Open. Research utilizing TriNetX’s analytics platform is aiding in establishing new standards for how real-world data influences various aspects of healthcare, such as clinical drug and vaccine development, evidence generation, and patient safety and effectiveness measures.

The exceptional growth in citations is closely linked to the rapid expansion of the TriNetX LIVE™ network, which has seen a significant increase in both healthcare partnerships and patient data. Over the past year, from September 2024 to September 2025, the network has nearly doubled its reach. Notably, growth in regions like Latin America surged by 70%, and the Asia Pacific region expanded by 31%.

“Our network's rapid expansion reflects the evolving interests of our clients and partners, spanning initiatives from drug discovery to clinical trial design and care delivery.” Steve Kundrot, the Chief Operating Officer of TriNetX, expressed, “The momentum in onboarding new healthcare organizations and expanding patient data fortifies the real-world evidence landscape internationally, making TriNetX an unparalleled resource for credible research.”

TriNetX operates the most extensive federated network of real-world data, collaborating with healthcare providers to drive innovation across the healthcare spectrum. Their platform prioritizes compliance with HIPAA, GDPR, and LGPD regulations while providing an anonymous, de-identified repository of electronic health record datasets.

With their growing influence in the research community, TriNetX continues to empower stakeholders to enhance clinical trial protocols, streamline operations, and enrich the overall generation of real-world evidence. For those interested in learning more about TriNetX’s datasets and analytics, they invite you to explore their offerings at www.trinetx.com or connect with them on LinkedIn. The future of healthcare research appears bright with TriNetX at the helm, leading the charge in the domain of real-world data.